Engineered Proteins for Targeted Full Spectrum Influenza Neutralization
Exclusively Licensed
Invention type: Technology
/
Case number: #13937
The present invention provides novel agents for broad spectrum influenza neutralization. The present invention provides agents for inhibiting influenza infection by bind to the influenza virus and/or hemagglutinin (HA) polypeptides and/or HA receptors, and reagents and methods relating thereto. The present invention provides a system for analyzing interactions between infolds and the interaction partners that bind to them.
Researchers
Ram Sasisekharan
/
Vidya Subramanian
/
Venkataramanan Soundararajan
/
Karthik Viswanathan
/
Sasisekharan Raguram
/
Viswanathan Sasisekharan
Departments: School of Engineering
Technology Areas: Drug Discovery and Research Tools: Antibodies / Therapeutics: Proteins & Antibodies
Impact Areas: Healthy Living
-
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Japan | Published application -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
United States of America | Granted | 8,637,456 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
European Patent Convention | Granted | 2,528,615 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Japan | Granted | 6,210,685 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Canada | Granted | 2,787,940 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Australia | Granted | 2,011,210,840 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
United States of America | Granted | 9,334,309 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Japan | Published application -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
United States of America | Granted | 9,572,861 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Germany | Granted | 2,528,615 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Spain | Granted | 2,528,615 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
France | Granted | 2,528,615 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
United Kingdom | Granted | 2,528,615 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Italy | Granted | 2,528,615
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.